Clopidogrel and Antinuclear antibody increased - a phase IV clinical study of FDA data

Summary:

Antinuclear antibody increased is reported as a side effect among people who take Clopidogrel (clopidogrel), especially for people who are female, 50-59 old, also take Tegretol, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Antinuclear antibody increased when taking Clopidogrel. It is created by eHealthMe based on reports of 91,038 people who have side effects when taking Clopidogrel from the FDA, and is updated regularly.

What is Clopidogrel?

Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.

What is Antinuclear antibody increased?

Antinuclear antibody increased is found to be associated with 148 drugs and 360 conditions by eHealthMe. Check the latest studies of Antinuclear antibody increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

91,038 people reported to have side effects when taking Clopidogrel.
Among them, 11 people (0.01%) have Antinuclear antibody increased.

Could Clopidogrel cause Antinuclear antibody increased?

Among these 11 people:

What is the gender of people who have Antinuclear antibody increased when taking Clopidogrel? *

female: 90.91 %
male: 9.09 %

What is the age of people who have Antinuclear antibody increased when taking Clopidogrel? *

What are other drugs people take besides Clopidogrel? *

What are other side effects people have besides Antinuclear antibody increased? *

Pain In Extremity: 10 people, 90.91%
Ankle Brachial Index Decreased: 9 people, 81.82%
Double Stranded Dna Antibody Positive: 9 people, 81.82%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 81.82%
Insomnia (sleeplessness): 9 people, 81.82%
Weakness: 9 people, 81.82%
Peripheral Ischaemia (impaired circulation to an extremity): 9 people, 81.82%
Herpes Zoster: 9 people, 81.82%
Dizziness: 9 people, 81.82%
Concomitant Disease Aggravated (advanced due to some of accompanying): 9 people, 81.82%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 81.82%
Neuralgia (pain in one or more nerves): 6 people, 54.55%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 9.09%
Pain: 1 person, 9.09%
Non-Small Cell Lung Cancer Recurrent (type of epithelial lung cancer reoccurrence): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Clopidogrel and have Antinuclear antibody increased?

- Check whether Antinuclear antibody increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clopidogrel:

Clopidogrel (92,160 reports)

Browse all side effects of Clopidogrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Antinuclear antibody increased:

Antinuclear antibody increased (148 drugs)

Browse all the conditions that are associated with Antinuclear antibody increased:

Antinuclear antibody increased (360 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on clopidogrel (the active ingredients of Clopidogrel) and Clopidogrel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.